The Lead Episode 107: A Discussion of Catheter Ablation of AFib Patients with Cardiac Amyloidosis and Sarcoidosis: Procedural Outcomes and Findings LIVE from Heart Rhythm 2025-The Lead Episode 107 Speaker Information

The Lead Episode 107 Speaker Information

Pdf Summary

The discussion hosted by Prashanthan Sanders, MBBS, PhD, FHRS focuses on the procedural outcomes and findings of catheter ablation for atrial fibrillation (Afib) in patients with cardiac amyloidosis and sarcoidosis. The article under discussion, published in the Heart Rhythm Journal, was authored by a team led by Alireza Oraii, alongside several co-authors.<br /><br />Catheter ablation is a procedure used to treat atrial fibrillation, a common heart rhythm disorder, by destroying areas of heart tissue that cause irregular heartbeats. This discussion aims to address the effectiveness and outcomes of the procedure specifically in patients suffering from cardiac amyloidosis and sarcoidosis, two conditions marked by abnormal protein deposits and inflammatory granulomas in the heart, respectively. These conditions can complicate heart treatment due to their unique pathophysiology and potential to exacerbate heart function.<br /><br />The panel for the discussion includes notable contributors such as Takanori Yamaguchi, MD, PhD from Saga University, and Louise Segan, MBBS, MPH from Alfred Health. Prashanthan Sanders, who serves as the host, is affiliated with the University of Adelaide and has disclosed affiliations and consultancies with several medical technology companies including Boston Scientific and Medtronic.<br /><br />Dr. Yamaguchi also has numerous consultancies with pharmaceutical and medical device companies, while Dr. Segan reported no disclosures. The array of expertise among the contributors provides a comprehensive examination of the procedural techniques, challenges, and outcomes specific to patients with these complex cardiac conditions, contributing valuable insights into potential improvements in clinical practices for treating Afib in these patient populations. <br /><br />This session facilitates a deeper understanding of how to manage and tailor treatments effectively for Afib patients with concurrent cardiac amyloidosis and sarcoidosis.

Keywords

catheter ablation

atrial fibrillation

cardiac amyloidosis

sarcoidosis

Heart Rhythm Journal

Prashanthan Sanders

Alireza Oraii

heart treatment

abnormal protein deposits

inflammatory granulomas